FOR INVESTORS
Investors
We create new and innovative products with shorter time to market and mitigated risk. We make his possible by combining materials science & pharmaceutical development and by using established and approved active substances.
BioStock interview, April 2022
Five questions to CEO Torbjörn W Larsson
- You summarize your vision as: Introducing a new generation of products for a better tomorrow. Can you develop what that means?
- Why did you decide to focus on innovation in drug delivery, especially in pain relief?
- What are bioceramic materials and how does Emplicure use them?
- Your wholly owned subsidiary Amplicon uses the same bioceramic platforms as Emplicure, but for a different indication. Can you tell me more?
- Looking ahead, what will be your main focus over the next six months?
800+
Investors
7
Patent families
53
Patents
2014
Founded
BIOCERAMIC TECHNOLOGIES
Technologies for new and innovative products, as well as better user experiences
Emplicure is structured around two business areas, pharmaceutical products and consumer goods, both introducing innovative products based on Emplicure’s patented bioceramic technology platforms. All products target large markets and unmet medical needs, are financially viable, and are based on existing pharmaceutical ingredients. Emplicure and the subsidiary Amplicon share joint administration platforms for different administration routes.